植物转录抑制子的结构特征及其作用机理

转录因子依转录调控能力可分为激活子和抑制子。植物转录抑制蛋白的分类依据很多,从作用方式上可分为主动抑制子和被动抑制子两大类：根据与DNA结合的方式则可分为锌指类、MYB类、AP2／EREBP类、bHLH类和bZlP类等。植物主动抑制子通过其含有的抑制域对转录直接起抑制作用。抑制域又可分很多类,但多数为含有类似EAR基序的保守性基序,其上具有几个保守性亮氨酸残基。植物转录抑制子主要通过对激活子或基本转录复合物产生作用及改变染色体结构3种方式来抑制目标基因的转录。有关植物转录抑制子的研究虽很欠缺,但以拟南芥SUPERMAN等抑制子的EAR基序为代表的研究表明,抑制域是阐明植物转录抑制子功能和下游基因表达调控机理的核心对象,而融合抑制子沉默技术（CRES-T）也为人为调控基因沉默带来了新的技术手段。     

中枢神经系统的突触前抑制

中枢神经系统的抑制过程是中枢神经系统的基本神经过程之一,中枢抑制分突触前抑制和突触后抑制,本文主要综述有关突触前抑制问题,为研究中枢抑制和针刺镇痛原理提供一些资料。一、突触前抑制和突触后抑制现在一般认为,中枢抑制过程进行的部位主要在突触,中枢抑制实际上就是突触抑制。自从 Eccles 等对这个问题进行研究以来,一般将突触抑制分为两种,即突触前抑制和突触     

植物转录抑制子的结构特征及其作用机理

转录因子依转录调控能力可分为激活子和抑制子。植物 转录抑制蛋白的分类依据很多, 从作用方式上可分为主动抑制子和被动抑制子两大类; 根据与DNA结合的方式则可分为锌指类、MYB类、AP2/EREBP类、bHLH类和bZIP类等。植物主 动抑制子通过其含有的抑制域对转录直接起抑制作用。抑制域又可分很多类, 但多数为含有类似EAR基序的保守性基序, 其上具有几个保守性亮氨酸残基。植物转录抑制子主要通过对激活子或基本转录复合物产生作用及改变染色体结构3种方式来抑制目标基因的转录。有关植物转录抑制子的研究虽很欠缺, 但以拟南芥SUPERMAN等抑制子的EAR基序为代表的研究表明, 抑制域是阐明植物转录抑制子功能和下游基因表达调控机理的核心对象, 而融合抑制子沉默技术(CRES-T)也为人为调控基因沉默带来了新的技术手段。     

9种中药提取物黄嘌呤氧化酶抑制活性研究

本文考察9种中药植物(葛花、卷柏、卷柏根、猫须草、鹅不食草、高良姜、绞股蓝、鸡骨草、金银花)提取物对黄嘌呤氧化酶抑制活性。结果表明9种中药提取物在2 mg/mL时均具有较好抑制活性,抑制率从33%~79%不等。葛花、猫须草和金银花半抑制浓度分别是0.65、0.96、0.74 mg/mL,且猫须草、葛花抑制类型属于竞争性抑制为主的复合抑制。     

人血管生成抑制素抑瘤研究进展

肿瘤的发展和转移需要新生血管的形成。人血管生成抑制素是近年发现的能够专一性抑制血管内皮细胞的内皮抑制因子。大量研究表明,在体外用血管生成抑制素处理血管内皮细胞可以抑制新生血管的形成,在体内单独使用血管生成抑制素,或者将血管生成抑制素与其他物质如基质金属蛋白酶、尿激酶联合处理荷瘤小鼠,可以降低小鼠体内肿瘤组织新生血管密度,抑制肿瘤的生长和肿瘤细胞的迁移。简要综述了血管生成抑制素抑制肿瘤生长和转移及其作用机理。     

植物病毒基因沉默抑制子研究进展

RNAi普遍存在于真核生物中,是植物应对外来病毒入侵的一种防御机制。但是植物病毒能通过产生不同的抑制子蛋白来抑制寄主基因沉默的发生。病毒抑制子通过干扰基因沉默的起始、siRNA的积累或干扰系统性基因沉默等方式抑制寄主的基因沉默。有的病毒抑制子蛋白还能促进病毒的积累和胞间移动,加强侵染组织的病毒病症状表现。主要阐述了RNAi的机制、病毒抑制PTGS的作用方式、几种常见的沉默抑制子以及抑制子与病毒侵染的关系。     

重组肌肉抑制素功能分析及其对鸡肌肉发育的抑制作用

肌肉抑制素 (myostatin)为TGF β超家族成员 ,具有典型的TGF β家族成员特有的分子结构与功能。为了深入阐明肌肉抑制素的作用机制 ,研究了重组肌肉抑制素蛋白对鸡胚成肌细胞和小鼠C2 C1 2 成肌细胞增殖与分化的作用 ,同时制备了肌肉抑制素特异性抗体。实验结果表明 ,重组肌肉抑制素对于成肌细胞的增殖过程具有极强的抑制作用 ,主要表现为抑制细胞周期由G1 期向S期的过渡 ,细胞生长速度显著变慢 ;同时重组肌肉抑制素也抑制成肌细胞分化为多核的融合肌管细胞 ,抑制肌肉分化标志myogenin和MHC的表达。由重组蛋白质制备的抗体能够特异性地识别人、小鼠、大鼠和鸡肌肉组织的内源肌肉抑制素。此外 ,通过免疫荧光技术还证实 ,肌肉抑制素主要定位于胞液中     

动物生殖抑制研究进展：理论模型、方式和机制

生殖抑制指原本具有生育能力的动物个体因特定外界环境或生理条件而减少或丧失生殖能力的现象,有时是受环境变化的主动调控,更多的是出现在其他个体影响下的被动抑制,极端情况发生在社会性动物的永久性抑制,即永久无法生殖或无法生殖成熟。研究发现非社会性动物也有生殖的推迟及可恢复性的生殖抑制,生殖抑制影响着动物种群数量动态、维持和进化。随着多学科的发展,生殖抑制机理研究取得了诸多进展。从阐述生殖抑制的概念出发,解析生殖抑制的形态、激素和分子生理特征,总结了生殖抑制的原因、作用,终述现有的理论模型以及不同物种方面的最新进展,并就生殖抑制在生物资源管理方面的应用价值进行了展望,旨在丰富生殖抑制的理论,扩展应用实践,为后续的生物资源管理提供理论参考。     

兔下丘脑室旁核刺激引起的肾交感神经传出活动的抑制

本实验用家兔,氯醛糖及尿酯混合静脉麻醉,制动,人工呼吸,颈部分离出三对神经——迷走、窦及主动脉神经,以备实验中切断。记录股动脉压、肾交感神经传出性放电活动(RSED)及其频率幅度直方图。借助脑立体定向仪刺激下丘脑室旁核,当刺激较强时,在交感神经放电短暂增加之后,可引起血压升高及RSED抑制。这一抑制过程可分为两个时相:血压不变期间的初期抑制时相及与血压升高同时并存的后期抑制时相。实验发现RSED总抑制时程及后期抑制时程均与血压变动具有正相关关系,而初期抑制时程与血压变动无相关关系。切断压力感受性神经前后,虽初期抑制时程的均值无显著差异,但在切断压力感受性神经后,总抑制时程及后期抑制时程的均值大大缩短。当用较弱刺激施于室旁核时,可不引起血压变化,但仍能引起RSED抑制。这个抑制亦可因切断压力感受神经而显著缩短。上述实验结果表明:(1) 在中枢内存在着一个室旁核-肾交感传出系统的抑制机制;(2) 初期抑制来源于中枢性抑制机制,而后期抑制时相主要来源于压力感受性反射,但亦有中枢抑制机制的参与;(3) RSED的中枢抑制可能并不是兴奋后压抑,而是自室旁核至脊髓交感节前神经元的主动性抑制。     

种子萌发的抑制调控机制

种子萌发是植物生命周期中一个重要的生理过程,激素作用、miRNA抑制、mRNA区域化、表观遗传调控等多个层次的分子抑制参与该过程的调控。赤霉素（解除抑制的激素）合成和失活的调控主要发生在转录水平,而脱落酸（引起抑制的激素）信号转导途径的调控则通过蛋白质抑制物的降解来实现。miRNA在转录后水平使其靶基因的mRNA降解,抑制种子的萌发;通过mRNA的区域化抑制与萌发相关基因的翻译属于另一层次的转录后抑制;小RNA介导的表观遗传机制也可能在种子萌发过程基因表达的协同调控中发挥重要作用。与分子水平的抑制类似,胚乳和种皮产生的机械抑制也很重要。     

Down-regulation of TSG101 by small interfering RNA inhibits the proliferation of breast cancer cells through the MAPK/ERK signal pathway

We designed to investigate the effects of down-regulating the tumor susceptibility gene 101 (TSG101) on the proliferation and apoptosis of the human breast cancer MCF-7 cell line, and the role of the MAPK/ERK signal pathway in this process. The siRNA against TSG101 was transfected into the breast cancer MCF-7 cell line using Lipofectamine 2000. After TSG101 knockdown, the proliferation of MCF-7 cells was measured by the MTT assay. The cell cycle distribution and apoptosis were examined by using flow cytometry while cell migration was measured using a transwell assay. The protein level of p-ERK was further assessed by immunofluorescence and western blotting. Our results are as following, the MCF-7 cells transfected with TSG101 siRNA proliferated significantly slower and exhibited significantly increased rates of apoptosis compared to the control cells. In the TSG101 siRNA transfected cells, the percentage of cells in the G?/G? and S phase of the cell cycle was significantly higher and lower, respectively, compared to the control cells. Moreover, the migration ability of TSG101 siRNA transfected cells was lower than the control groups. Lastly, the level of p-ERK protein in TSG101 siRNA transfected cells was significantly decreased compared with the control cells. In conclusion, TSG101 knockdown in breast cancer cells induces apoptosis and inhibits proliferation. The TSG101 depleted cells are arrested at the G?/S transition of the cell cycle. The migration of breast cancer cells is also impaired by TSG101 siRNA. TSG101 may play a biological role through modulation of the MAPK/ERK signaling pathway in breast cancer.     

Identification of TSG101 Functional Domains and p21 Loci Required for TSG101-Mediated p21 Gene Regulation

TSG101 (tumor susceptibility gene 101) is a multi-domain protein known to act in the cell nucleus, cytoplasm, and periplasmic membrane. Remarkably, TSG101, whose location within cells varies with the stage of the cell cycle, affects biological events as diverse as cell growth and proliferation, gene expression, cytokinesis, and endosomal trafficking. The functions of TSG101 additionally are recruited for viral and microvesicle budding and for intracellular survival of invading bacteria. Here we report that the TSG101 protein also interacts with and down-regulates the promoter of the p21^CIP1/WAF1tumor suppressor gene, and identify a p21 locus and TSG101 domains that mediate this interaction. TSG101 deficiency in Saos-2 human osteosarcoma cells was accompanied by an increased abundance of p21 mRNA and protein and the retardation of cell proliferation. A cis-acting element in the p21 promoter that interacts with TSG101 and is required for promoter repression was located using chromatin immunoprecipitation (ChIP) analysis and p21-driven luciferase reporter gene expression, respectively. Additional analysis of TSG101 deletion mutants lacking specific domains established the role of the central TSG101 domains in binding to the p21 promoter and demonstrated the additional essentiality of the TSG101 C-terminal steadiness box (SB) in the repression of p21 promoter activity. Neither binding of TSG101 to the p21 promoter nor repression of this promoter required the TSG101 N-terminal UEV domain, which mediates the ubiquitin-recognition functions of TSG101 and its actions as a member of ESCRT endocytic trafficking complexes, indicating that regulation of the p21 promoter by TSG101 is independent of its role in such trafficking.     

TSG101 expression in gynecological tumors: relationship to cyclin D1, cyclin E, p53 and p16 proteins.

Recent studies have shown that in vitro steady-state expression of the tumor susceptibility gene TSG101 is important for maintenance of genomic stability and cell cycle regulation. To determine the contribution of TSG101 expression in neoplastic formation, expression of TSG101 protein levels were evaluated in primary ovarian and endometrial adenocarcinoma tumors. Expression of TSG101 was also examined in various tumor cell lines (PA-1, AN3CA, HeLa, HS578T, HCT116). Full-length TSG101 protein was detected in these tumors and cell lines indicating that intragenic deletions were not characteristic of TSG101. In addition, TSG101 protein levels were compared with aberrations of prominent cell cycle regulatory molecules such as cyclin D1, cyclin E, p16 and p53. Reduced TSG101 protein was observed in 36% (8/22) of ovarian and 17% (1/6) of endometrial adenocarcinoma. Aberrant levels of p53, p16, cyclin D or E were comparable to published studies indicating that the clinicopathological distribution of these cases did not favor advanced stage tumors. Altogether, these findings suggest that a down-regulation of TSG101 is associated with tumorigenesis in a subgroup of gynecological tumors.     

二苯乙烯苷抑制过氧化氢诱导的人脐静脉内皮细胞凋亡

目的：研究二苯乙烯苷（TSG）对过氧化氢（H2O2）诱导人脐静脉内皮细胞（HUVECs）凋亡的保护作用。方法：运用四甲基偶氮唑盐还原法（MTT法）和流式细胞术筛选建立细胞凋亡模型的H2O2合适浓度以及检测不同浓度TSG对H2O2诱导HUVECs的增殖率和凋亡率;Hoechst33258染色观察细胞凋亡形态。结果：MTT及流式法筛选300μmol/L为H2O2作用于细胞的最适凋亡浓度。MTT和流式结果显示,与H2O（2300μmol/L）损伤组比较,10μmol/L与100μmol/LTSG预处理组细胞的增殖率增加（P〈0.05）,凋亡率显著降低（P〈0.01）;Hoechst33258染色观察TSG能降低H2O2诱导的细胞凋亡,使细胞凋亡数减少。结论：TSG能抑制H2O2诱导的HUVECs凋亡,从而起到保护血管内皮细胞的作用。     

HD-PTP and Alix share some membrane-traffic related proteins that interact with their Bro1 domains or proline-rich regions

Mammalian Alix is a multifunctional adaptor protein involved in cell death, receptor endocytosis, endosomal protein sorting and cell adhesion by associating with various proteins such as ALG-2, CIN85/Rukl/SETA, endophilins, CHMP4s and TSG101. HD-PTP is a paralog of Alix and a putative protein tyrosine phosphatase (PTP) that contains a Bro1 domain, coiled-coils, a proline-rich region (PRR) in addition to a PTP domain. We investigated interactions between HD-PTP and Alix-binding proteins. In the yeast two-hybrid assay, HD-PTP showed positive interactions with CHMP4b/Shax1, TSG101, endophilin A1 and ALG-2 but not with either RabGAPLP or CIN85. We confirmed the interactions in a mammalian system by Strep-pulldown assays in which pulldown products from the lysates of HEK293T cells expressing either Strep-tagged HD-PTP alone or co-expressing with epitope-tagged proteins were analyzed by Western blotting using specific antibodies. While Alix associated with both ALG-2 and TSG101 in a Ca2+-dependent manner, HD-PTP interacted with ALG-2 Ca2+-dependently but with TSG101 Ca2+-independently.     

二苯乙烯苷对动脉硬化大鼠主动脉金属蛋白酶2，9表达的影响

目的：观察二苯乙烯苷（TSG）对动脉硬化大鼠主动脉基质金属蛋白酶2,9（MMP-,9）表达的影响,探讨TSG治疗动脉粥样硬化、稳定斑块的可能机制。方法：采用高脂饲料喂饲＋VitD3复制大鼠动脉粥样硬化模型。SD大鼠60只,雄性,随机分为6组（n=10）：正常组;阳性药组;模型组;TSG120mg·kg^-1·d^-1组;TSG60mg·kg^-1·d^-1组;TSG30,mg·kg^-1·d^-1组。造模给药12周后抽样检测大鼠主动脉,以大鼠动脉粥样硬化斑块形成为造模指标,经治疗6周后,蛋白免疫印迹、逆转录聚合酶反应法观察各组动脉MMP-2,9的蛋白和mRNA表达;检测血清GRP;ELISA法测定血清IL-6和TNF-α。结果：TSG120mg·kg^-1·d^-1和TSG60mg·kg^-1·d^-1能显著降低血清IL-6、TNF-α、CRP和动脉MMP-2,9表达,并呈剂量依赖性。结论：TSG对高脂饲料＋VitD3诱导大鼠动脉粥样硬化具有治疗与稳定斑块作用,其机制可能与其抗炎作用、调节基质金属蛋白酶表达有关.     

TSG101 promotes the proliferation,migration and invasion of hepatocellular carcinoma cells by regulating the PEG10

The tumour susceptibility gene 101 (TSG101) is reported to play important roles in the development and progression of several human cancers. However, its potential roles and underlined mechanisms in human hepatocellular carcinoma (HCC) are still needed to be further clarified. In the present study, we reported that knock down of TSG101 suppressed the proliferation, migration and invasion of HCC cells, while overexpression of TSG101 facilitated them. Molecularly, the results revealed that knock down of TSG101 significantly decreased the cell cycle related regulatory factor p53 and p21. In another point, knock down of TSG101 also obviously decreased the level of metallopeptidase inhibitor TIMP1 (Tissue inhibitors of metalloproteinases 1), which results in inhibition of MMP2, MMP7 and MMP9. In contrast, overexpression of TSG101 had opposite effects. The iTRAQ proteomics analysis identified that oncogenic protein PEG10 (Paternally expressed gene 10) might be a potential downstream target of TSG101. Further investigation showed that TSG101 interacted with PEG10 and protected it from proteasomal degradation thereby regulating the expression of p53, p21 and MMPs. Finally, we found that both TSG101 and PEG10 proteins are up‐regulated and presented a direct correlation in HCC patients. In conclusion, these results suggest that TSG101 is up‐regulated in human HCC patients, which may accelerate the proliferation, migration and invasion of HCC cells through regulating PEG10.     

Protective effect of tetrahydroxystilbene glucoside on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway

Oxidative stress plays an important role in the pathogenesis of neurodegenerative diseases, such as Parkinson's disease. The molecule, 2,3,5,4'-tetrahydr- oxystilbene-2-O-β-D-glucoside (TSG), is a potent antioxidant derived from the Chinese herb, Polygonum multiflorum Thunb. In this study, we investigated the protective effect of TSG against 6-hydroxydopamine-induced apoptosis in rat adrenal pheochromocytoma PC12 cells and the possible mechanisms. Our data demonstrated that TSG significantly reversed the 6-hydroxydopamine-induced decrease in cell viability, prevented 6-hydroxydopamine-induced changes in condensed nuclei and decreased the percentage of apoptotic cells in a dose-dependent manner. In addition, TSG slowed the accumulation of intracellular reactive oxygen species and nitric oxide, counteracted the overexpression of inducible nitric oxide syntheses as well as neuronal nitric oxide syntheses, and also reduced the level of protein-bound 3-nitrotyrosine. These results demonstrate that the protective effects of TSG on rat adrenal pheochromocytoma PC12 cells are mediated, at least in part, by the ROS-NO pathway. Our results indicate that TSG may be effective in providing protection against neurodegenerative diseases associated with oxidative stress.